These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34405620)

  • 1. [Comparison of two antibodies for measuring HER2 expression in gallbladder adenocarcinomas].
    Chen LL; Huang J; Yu ZX; Luo RK; Jiang DX; Gao F; Xu L; Zhang XL; Su JAKS; Ji Y; Hou YY
    Zhonghua Bing Li Xue Za Zhi; 2021 Jul; 50(7):805-807. PubMed ID: 34405620
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of HER2 positivity in gallbladder adenocarcinoma].
    Yao JG; Wang CH; Liu Y
    Zhonghua Bing Li Xue Za Zhi; 2017 Apr; 46(4):245-248. PubMed ID: 28376590
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of Human Epidermal Growth Factor Receptor (Her 2/neu) and Proliferative Marker Ki-67: Association with Clinicopathological Parameters in Gallbladder Carcinoma.
    Pujani M; Makker I; Makker A; Jetley S; Goel MM; Jetley S
    Asian Pac J Cancer Prev; 2016; 17(8):3903-9. PubMed ID: 27644637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of HER2 and Ki-67 in Preneoplastic Lesions and Carcinoma of Gallbladder.
    Halder S; Kundu S; Chakraborty J; Chakrabarti S
    J Gastrointest Cancer; 2019 Dec; 50(4):848-854. PubMed ID: 30155833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor and HER-2/neu status by immunohistochemistry and fluorescence in situ hybridization in adenocarcinomas of the biliary tree and gallbladder.
    Shafizadeh N; Grenert JP; Sahai V; Kakar S
    Hum Pathol; 2010 Apr; 41(4):485-92. PubMed ID: 20040392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing for ROS1, ALK, MET, and HER2 rearrangements and amplifications in a large series of biliary tract adenocarcinomas.
    Augustin J; Gabignon C; Scriva A; Menu L; Calmel C; Scatton O; Paye F; Fléjou JF; Praz F; Cervera P; Wendum D
    Virchows Arch; 2020 Jul; 477(1):33-45. PubMed ID: 32447492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2 gene (ERBB2) amplification is a low-frequency driver with potential predictive value in gallbladder carcinoma.
    Albrecht T; Rausch M; Roessler S; Geissler V; Albrecht M; Halske C; Seifert C; Renner M; Singer S; Mehrabi A; Vogel MN; Pathil-Warth A; Busch E; Köhler B; Rupp C; Weiss KH; Springfeld C; Röcken C; Schirmacher P; Goeppert B
    Virchows Arch; 2020 Jun; 476(6):871-880. PubMed ID: 31838585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive expression of ErbB-2 in gallbladder epithelium results in development of adenocarcinoma.
    Kiguchi K; Carbajal S; Chan K; Beltrán L; Ruffino L; Shen J; Matsumoto T; Yoshimi N; DiGiovanni J
    Cancer Res; 2001 Oct; 61(19):6971-6. PubMed ID: 11585718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gallbladder cancers rarely overexpress HER-2/neu, demonstrated by Hercep test.
    Matsuyama S; Kitajima Y; Sumi K; Mori D; Satoh T; Miyazaki K
    Oncol Rep; 2004 Apr; 11(4):815-9. PubMed ID: 15010878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of HER2 and bradykinin B₁ receptors in precursor lesions of gallbladder carcinoma.
    Toledo C; Matus CE; Barraza X; Arroyo P; Ehrenfeld P; Figueroa CD; Bhoola KD; Del Pozo M; Poblete MT
    World J Gastroenterol; 2012 Mar; 18(11):1208-15. PubMed ID: 22468084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder.
    Kamel D; Pääkkö P; Nuorva K; Vähäkangas K; Soini Y
    J Pathol; 1993 May; 170(1):67-72. PubMed ID: 8100854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic implication of HER2 in advanced biliary tract cancer.
    Nam AR; Kim JW; Cha Y; Ha H; Park JE; Bang JH; Jin MH; Lee KH; Kim TY; Han SW; Im SA; Kim TY; Oh DY; Bang YJ
    Oncotarget; 2016 Sep; 7(36):58007-58021. PubMed ID: 27517322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Female Sex Hormone Receptors, Connective Tissue Growth Factor and HER2 in Gallbladder Cancer.
    Hryciuk B; Pęksa R; Bieńkowski M; Szymanowski B; Radecka B; Winnik K; Żok J; Cichowska N; Iliszko M; Duchnowska R
    Sci Rep; 2020 Feb; 10(1):1871. PubMed ID: 32024900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER2 status in gastro-oesophageal adenocarcinomas assessed by two rabbit monoclonal antibodies (SP3 and 4B5) and two in situ hybridization methods (FISH and SISH).
    Boers JE; Meeuwissen H; Methorst N
    Histopathology; 2011 Feb; 58(3):383-94. PubMed ID: 21323962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of BDNF and BMPR1A with clinicopathologic parameters in benign and malignant gallbladder lesions.
    Xiong L; Deng X; Wen Y; Yang Z; Miao X
    World J Surg Oncol; 2013 Mar; 11():80. PubMed ID: 23531103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR expression in gallbladder carcinoma in North America.
    Kaufman M; Mehrotra B; Limaye S; White S; Fuchs A; Lebowicz Y; Nissel-Horowitz S; Thomas A
    Int J Med Sci; 2008 Sep; 5(5):285-91. PubMed ID: 18825277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of HER2/neu expression in primary gastroesophageal adenocarcinomas using conventional light microscopy and quantitative image analysis.
    Jeung J; Patel R; Vila L; Wakefield D; Liu C
    Arch Pathol Lab Med; 2012 Jun; 136(6):610-7. PubMed ID: 22646266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer in Indian patients manuscript id: 8962091628764582.
    Chaube A; Tewari M; Garbyal RS; Singh U; Shukla HS
    BMC Cancer; 2006 May; 6():126. PubMed ID: 16686942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Squamous carcinoma of the gallbladder. Anatomo-clinical study of a case with reference to oncogene expression].
    Botto Micca F; Coda R; Giordano F; Bona A; Bossotti M; Benedetto C
    Pathologica; 1997 Feb; 89(1):77-80. PubMed ID: 9312737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessment.
    Kunz PL; Mojtahed A; Fisher GA; Ford JM; Chang DT; Balise RR; Bangs CD; Cherry AM; Pai RK
    Appl Immunohistochem Mol Morphol; 2012 Jan; 20(1):13-24. PubMed ID: 21617522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.